TY - JOUR AU - Cheung, N. AU - Mitchell, P. AU - Wong, T. Y. PY - 2010 DA - 2010// TI - Diabetic retinopathy JO - Lancet (London, England) VL - 376 UR - https://doi.org/10.1016/S0140-6736(09)62124-3 DO - 10.1016/S0140-6736(09)62124-3 ID - Cheung2010 ER - TY - STD TI - Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology. 1978;85(1):82–106. https://pubmed.ncbi.nlm.nih.gov/345173/. UR - https://pubmed.ncbi.nlm.nih.gov/345173/ ID - ref2 ER - TY - JOUR PY - 1991 DA - 1991// TI - ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group JO - Ophthalmology VL - 98 ID - ref3 ER - TY - STD TI - Martinez-Zapata MJ, Marti-Carvajal AJ, Sola I, Pijoan JI, Buil-Calvo JA, Cordero JA, et al. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014;(11):Cd008721. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008721.pub2/full?cookiesEnabled. UR - https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008721.pub2/full?cookiesEnabled ID - ref4 ER - TY - STD TI - Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–86. https://doi.org/10.1016/j.preteyeres.2015.08.001. ID - ref5 ER - TY - JOUR AU - Li, X. AU - Zarbin, M. A. AU - Bhagat, N. PY - 2017 DA - 2017// TI - Anti-vascular endothelial growth factor injections: the new standard of Care in Proliferative Diabetic Retinopathy? JO - Dev Ophthalmol VL - 60 UR - https://doi.org/10.1159/000459699 DO - 10.1159/000459699 ID - Li2017 ER - TY - STD TI - Azad AD, Chen EM, Hinkle J, Rayess N, Wu D, Eliott D, et al. Anti-vascular endothelial growth factor and Panretinal photocoagulation use after protocol S for proliferative diabetic retinopathy. Ophthalmol Retin. 2020. https://doi.org/10.1016/j.oret.2020.10.002. ID - ref7 ER - TY - JOUR AU - Chatziralli, I. AU - Dimitriou, E. AU - Theodossiadis, G. AU - Kazantzis, D. AU - Theodossiadis, P. PY - 2020 DA - 2020// TI - Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study JO - Acta Diabetol VL - 57 UR - https://doi.org/10.1007/s00592-020-01548-y DO - 10.1007/s00592-020-01548-y ID - Chatziralli2020 ER - TY - STD TI - Filho JA, Messias A, Almeida FP, Ribeiro JA, Costa RA, Scott IU, et al. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Acta Ophthalmol. 2011;89(7):e567–72. https://doi.org/10.1111/j.1755-3768.2011.02184.x. ID - ref9 ER - TY - JOUR AU - Ali, W. AU - Abbasi, K. Z. AU - Raza, A. PY - 2018 DA - 2018// TI - Panretinal photocoagulation plus Intravitreal Bevacizumab versus Panretinal photocoagulation alone for proliferative diabetic retinopathy JO - J Coll Phys Surgeons Pak VL - 28 UR - https://doi.org/10.29271/jcpsp.2018.12.923 DO - 10.29271/jcpsp.2018.12.923 ID - Ali2018 ER - TY - JOUR AU - Kartasasmita, A. AU - Harley, O. PY - 2019 DA - 2019// TI - Evaluation of the timing of intravitreal bevacizumab injection as adjuvant therapy to panretinal photocoagulation in patients with diabetic macular edema secondary to diabetic retinopathy JO - Clin Ophthalmol (Auckland, NZ) VL - 13 UR - https://doi.org/10.2147/OPTH.S216790 DO - 10.2147/OPTH.S216790 ID - Kartasasmita2019 ER - TY - JOUR AU - Mirshahi, A. AU - Ghassemi, F. AU - Fadakar, K. AU - Mirshahi, R. AU - Bazvand, F. AU - Riazi-Esfahani, H. PY - 2019 DA - 2019// TI - Effects of panretinal photocoagulation on retinal vasculature and foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography: a pilot study JO - J Curr Ophthalmol VL - 31 UR - https://doi.org/10.1016/j.joco.2019.06.001 DO - 10.1016/j.joco.2019.06.001 ID - Mirshahi2019 ER - TY - JOUR AU - Kartasasmita, A. S. AU - Takarai, S. AU - Switania, A. AU - Enus, S. PY - 2016 DA - 2016// TI - Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion JO - Clin Ophthalmol (Auckland, NZ) VL - 10 UR - https://doi.org/10.2147/OPTH.S116745 DO - 10.2147/OPTH.S116745 ID - Kartasasmita2016 ER - TY - STD TI - Li X, Xu G, Wang Y, Xu X, Liu X, Tang S, et al. Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study. Ophthalmology. 2014;121(9):1740–7. https://doi.org/10.1016/j.ophtha.2014.03.026. ID - ref14 ER - TY - JOUR AU - Li, F. AU - Sun, M. AU - Guo, J. AU - Ma, A. AU - Zhao, B. PY - 2017 DA - 2017// TI - Comparison of Conbercept with Ranibizumab for the treatment of macular edema secondary to branch retinal vein occlusion JO - Curr Eye Res VL - 42 UR - https://doi.org/10.1080/02713683.2017.1285943 DO - 10.1080/02713683.2017.1285943 ID - Li2017 ER - TY - STD TI - Li F, Zhang L, Wang Y, Xu W, Jiao W, Ma A, et al. One-year outcome of Conbercept therapy for diabetic macular edema.Curr Eye Res. 2018;43(2):218–23. ID - ref16 ER - TY - STD TI - Hu Z, Su Y, Xie P, Chen L, Ji J, Feng T, et al. OCT angiography-based monitoring of neovascular regression on fibrovascular membrane after preoperative intravitreal conbercept injection. Graefes Arch Clin Exp Ophthalmol. 2019;257(8):1611–9. ID - ref17 ER - TY - STD TI - Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013;4(6):290–4. https://doi.org/10.4239/wjd.v4.i6.290. ID - ref18 ER - TY - JOUR PY - 1987 DA - 1987// TI - The Early Treatment Diabetic Retinopathy Study Research Group JO - Int Ophthalmol Clin VL - 27 UR - https://doi.org/10.1097/00004397-198702740-00005 DO - 10.1097/00004397-198702740-00005 ID - ref19 ER - TY - JOUR AU - Pokharel, A. AU - Shrestha, G. S. AU - Shrestha, J. B. PY - 2016 DA - 2016// TI - Macular thickness and macular volume measurements using spectral domain optical coherence tomography in normal Nepalese eyes JO - Clin Ophthalmol (Auckland, NZ) VL - 10 UR - https://doi.org/10.2147/OPTH.S95956 DO - 10.2147/OPTH.S95956 ID - Pokharel2016 ER - TY - STD TI - Chew EY, Ferris FL 3rd, Csaky KG, Murphy RP, Agrón E, Thompson DJ, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology. 2003;110(9):1683–9. https://doi.org/10.1016/S0161-6420(03)00579-7. ID - ref21 ER - TY - STD TI - Beaulieu WT, Bressler NM, Melia M, Owsley C, Mein CE, Gross JG, et al. Panretinal photocoagulation versus Ranibizumab for proliferative diabetic retinopathy: patient-centered outcomes from a randomized clinical trial. Am J Ophthalmol. 2016;170:206–13. https://doi.org/10.1016/j.ajo.2016.08.008. ID - ref22 ER - TY - STD TI - Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1617–24. ID - ref23 ER - TY - STD TI - Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, et al. Panretinal photocoagulation vs Intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. Jama. 2015;314(20):2137–46. https://doi.org/10.1001/jama.2015.15217. ID - ref24 ER - TY - STD TI - Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, et al. Five-year outcomes of Panretinal photocoagulation vs Intravitreous Ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136(10):1138–48. https://doi.org/10.1001/jamaophthalmol.2018.3255. ID - ref25 ER - TY - STD TI - Maguire MG, Liu D, Glassman AR, Jampol LM, Johnson CA, Baker CW, et al. Visual field changes over 5 years in patients treated with Panretinal photocoagulation or Ranibizumab for proliferative diabetic retinopathy. JAMA Ophthalmol. 2020;138(3):285–93. https://doi.org/10.1001/jamaophthalmol.2019.5939. ID - ref26 ER - TY - STD TI - Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132(11):1309–16. https://doi.org/10.1001/jamaophthalmol.2014.2350. ID - ref27 ER - TY - JOUR AU - Zhou, Q. AU - Guo, C. AU - You, A. AU - Wang, D. AU - Wang, W. AU - Zhang, X. PY - 2019 DA - 2019// TI - One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema JO - Mol Vis VL - 25 ID - Zhou2019 ER - TY - STD TI - Xu Y, Qu Y, Suo Y, Gao J, Chen X, Liu K, et al. Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment. BMC Ophthalmol. 2019;19(1):123. https://doi.org/10.1186/s12886-019-1131-0. ID - ref29 ER - TY - JOUR AU - Xu, Y. AU - Rong, A. AU - Xu, W. AU - Niu, Y. AU - Wang, Z. PY - 2017 DA - 2017// TI - Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study JO - BMC Ophthalmol VL - 17 UR - https://doi.org/10.1186/s12886-017-0554-8 DO - 10.1186/s12886-017-0554-8 ID - Xu2017 ER -